The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Plasma Phospholipid Trans Fatty Acids, Fatal Ischemic Heart Disease, and Sudden Cardiac Death in Older Adults: The Cardiovascular Health Study
Abstract
Background— Intake of trans fatty acids is associated with increased risk of coronary heart disease. Whether different classes of trans fatty acids show similar associations is unclear. We previously reported an association of sudden cardiac death with red cell membrane trans -18:2 but not trans -18:1 fatty acids. To extend these findings, we investigated the associations of plasma phospholipid trans fatty acids with fatal ischemic heart disease (IHD) and sudden cardiac death. Methods and Results— We conducted a case-control study nested in the Cardiovascular Health Study. We identified 214 cases of fatal IHD (fatal myocardial infarction and coronary heart disease death) between 1992 and 1998. We randomly selected 214 controls, matched to cases on demographics, prevalent cardiovascular disease, and timing of blood draw. Plasma phospholipid fatty acids were assessed in blood samples collected earlier. Higher levels of plasma phospholipid trans -18:2 fatty acids were associated with higher risk of fatal IHD (odds ratio [OR] for interquintile range 1.68, 95% confidence interval [CI] 1.21 to 2.33) after adjustment for risk factors and trans -18:1 levels. Trans -18:1 levels above the 20th percentile were associated with lower risk (OR 0.34, 95% CI 0.18 to 0.63). In analyses limited to cases of sudden cardiac death (n=95), higher levels of trans -18:2 fatty acids were associated with higher risk (OR 2.34, 95% CI 1.27 to 4.31) and higher trans -18:1 with lower risk (OR 0.18, 95% CI 0.06 to 0.54). Conclusions— Higher levels of trans -18:2 and lower levels of trans -18:1 fatty acids are associated with higher risks of fatal IHD and sudden cardiac death. If confirmed, these findings suggest that current efforts at decreasing trans fatty acid intake in foods should take into consideration the trans -18:2 content.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cardiovascular Health Study: design and rationale.
Fried, L. P., Borhani, N. O., Enright, P., Furberg, C. D., Gardin, J. M., Kronmal, R. A., Kuller, L. H., Manolio, T. A., Mittelmark, M. B., Newman, A., et al. (1991) · Annals of Epidemiology · doi:10.1016/1047-2797(91)90005-w · Cited by 3,652
Self-citationMensink, R. P., Zock, P. L., Kester, A. D., & Katan, M. B. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1146 · Cited by 2,811
Lopez-Garcia, E., Schulze, M. B., Meigs, J. B., Manson, J. E., Rifai, N., Stampfer, M. J., Willett, W. C., & Hu, F. B. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.3.562 · Cited by 600
Baer, D. J., Judd, J. T., Clevidence, B. A., & Tracy, R. P. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.6.969 · Cited by 476
Self-citationPrevention of Sudden Cardiac Death by Dietary Pure ω-3 Polyunsaturated Fatty Acids in Dogs
Billman, G. E., Kang, J. X., & Leaf, A. (1999) · Circulation · doi:10.1161/01.cir.99.18.2452 · Cited by 393
Cited by
de Souza, R. J., Mente, A., Maroleanu, A., Cozma, A. I., Ha, V., Kishibe, T., Uleryk, E., Budylowski, P., Schünemann, H., Beyene, J., et al. (2015) · BMJ · doi:10.1136/bmj.h3978 · Cited by 1,424
Health effects of trans-fatty acids: experimental and observational evidence
Mozaffarian, D., Aro, A., & Willett, W. C. (2009) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602973 · Cited by 662
Self-citationLemaitre, R. N., Tanaka, T., Tang, W., Manichaikul, A., Foy, M., Kabagambe, E. K., Nettleton, J. A., King, I. B., Weng, L.-C., Bhattacharya, S., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002193 · Cited by 411
Self-citationKramer, J. K. G., Hernandez, M., Cruz‐Hernandez, C., Kraft, J., & Dugan, M. E. R. (2008) · Lipids · doi:10.1007/s11745-007-3143-4 · Cited by 380
Mozaffarian, D., Cao, H., King, I. B., Lemaitre, R. N., Song, X., Siscovick, D. S., & Hotamisligil, G. S. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-12-201012210-00005 · Cited by 363
“Among 5,565 CHS participants alive in 1992, plasma phospholipid fatty acids were measured in 3,736 participants (67%), including 3,238 randomly selected participants from among individuals with available blood samples and an additional 498 participants from a prior nested casecontrol study within CHS of incident heart…”
MethodSelf-citationThe Evidence for Dietary Prevention and Treatment of Cardiovascular Disease
Van Horn, L., McCoin, M., Kris-Etherton, P. M., Burke, F., Carson, J. A. S., Champagne, C. M., Karmally, W., & Sikand, G. (2008) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2007.10.050 · Cited by 326
Dietary fatty acids and cardiovascular disease: An epidemiological approach
Erkkilä, A., de Mello, V. D. F., Risérus, U., & Laaksonen, D. E. (2008) · Progress in Lipid Research · doi:10.1016/j.plipres.2008.01.004 · Cited by 305
Trans Fatty Acids and Bioactive Lipids in Ruminant Milk
Shingfield, K. J., Chilliard, Y., Toivonen, V., Kairenius, P., & Givens, D. I. (2007) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-74087-4_1 · Cited by 291
Khaw, K.-T., Friesen, M. D., Riboli, E., Luben, R., & Wareham, N. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001255 · Cited by 291
“We only measured the two most common trans-fatty acids (16:1n9trans, 18:1n9trans). Though we were unable to assess the 18:2 transisomers associated with CHD in other studies”
BackgroundTissue n−3 and n−6 fatty acids and risk for coronary heart disease events
Harris, W. S., Poston, W. C., & Haddock, C. K. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.03.018 · Cited by 271
Kemp, A. H., Koenig, J., & Thayer, J. F. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.09.006 · Cited by 114
Zong, G., Sun, Q., Yu, D., Zhu, J., Sun, L., Ye, X., Li, H., Jin, Q., Zheng, H., Hu, F. B., et al. (2014) · Diabetes Care · doi:10.2337/dc13-0975 · Cited by 85
Background paper on global trends in food production, intake and composition
Wolmarans, P. (2009) · Annals of Nutrition and Metabolism · doi:10.1159/000229005 · Cited by 55
Trans-fatty acids and nonlipid risk factors
Wallace, S. K., & Mozaffarian, D. (2009) · Current Atherosclerosis Reports · doi:10.1007/s11883-009-0064-0 · Cited by 53
Self-citation
Metadata
- Authors
- Lemaitre, R. N., King, I. B., Mozaffarian, D., Sotoodehnia, N., Rea, T. D., Kuller, L. H., Tracy, R. P., & Siscovick, D. S.
- Venue
- Circulation
- Published
- 2006-07-18
- Volume
- 114
- Issue
- 3
- Pages
- 209-215
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2160369046
- Cited by
- 175
- References
- 5
- FWCI
- 10.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.